TrialAnnals of oncology : official journal of the European Society for Medical Oncology2017

Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer: secondary analysis of a randomized trial.

M Guberina et al.PubMed ↗Publisher ↗

No numbers read from the abstract.